The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study is aimed to explore the dual-dimensional early intervention strategy of standard
of care combined with host immunomodulation in elderly patients with mild and moderate
COVID-19.